🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT07114549
Recruiting Observational

External Validation of the MASCAN Score for the Classification of Difficult Mask Ventilation

NCT07114549 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2025-08-08
Last updated
2025-08-21

Condition(s) studied

Airway ManagementGeneral AnesthesiaMask Ventilation

Study summary

The MASCAN Score is a prospectively developed objective classification for difficult facemask ventilation. This prospective observational study aims to externally validate the MASCAN score in patients undergoing general anaesthesia for surgical procedures and to determine the influence of different approaches and techniques, such as the timing of neuromuscular blocking agents and manual versus controlled facemask ventilation. A secondary aim is to determine the diagnostic value of visual assessments of the capnography curve. Another secondary aim of the study is to compare the assessment of the first attempt success during tracheal intubation between the airway operator and an independent observer.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients who are scheduled for surgery with general anesthesia and require facemask ventilation and tracheal intubation after induction of anesthesia * Patients aged 18 years or older * Provided informed consent Exclusion Criteria: * Pregnant or breastfeeding woman * Required rapid sequence induction or other contraindications for facemask ventilation * Planned awake tracheal intubation * No consent given

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Medical Center Hamburg-Eppendorf Hamburg Free and Hanseatic City of Hamburg Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07114549 on ClinicalTrials.gov ↗ ← All trials in Germany